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In in vivo 1H spectroscopy, the signal at 1.32 ppm is usually
assigned to lactate. This resonance position is shared with
threonine at physiological pH. The similarity of spectral patterns
of lactate and threonine renders the separate measurement of
either threonine or lactate without and even with editing tech-
nically challenging. In this study, the threonine signal was de-
tected using a single-shot multiple-bond editing technique and
quantiﬁed in vivo in both rat and human brains. A threonine
concentration was estimated at 0.8  0.3 mM (mean  SD, n 
6) in the rat brain and at 0.33 mM in the human brain. Magn
Reson Med 59:245–251, 2008. © 2008 Wiley-Liss, Inc.
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In in vivo 1H spectroscopy, the signal at 1.32 ppm is
usually assigned to lactate (1,2), but this resonance posi-
tion is shared with threonine at physiological pH. Lactate
and threonine completely overlap at 1.32 ppm with the
same chemical shift and the same J-splitting. Additionally,
the closest J-coupled partners of the 1.32-ppm resonance
of lactate and threonine resonate at 4.11 and 4.24 ppm,
respectively, and they are typically not observed due to
weak spectral representation and their close proximity to
the water resonance. Another resonance of threonine at
3.58 ppm is overlapped by many other stronger reso-
nances. Due to the above characteristics, measurement of
either threonine or lactate alone is very difﬁcult, even with
spectral editing.
Presence of threonine in the human brain was reported
based on a study using autopsied brains, and the concen-
tration of threonine varied from 0.30  0.09 mol/(g wet
weight) to 0.79  0.37 mol/(g wet weight) in different
regions of the brain (3). The concentration of threonine in
the occipital cortex was reported as 0.42  0.16 mol/(g
wet weight). Threonine was also detected in vitro in the
tissue of normal rat thymus glands and malignant tumors
produced by S49 T-murine lymphoma cells (4), and in
vitro in cell cultures of normal glial cells and of intracra-
nial tumors (5) using 2D-COSY (COrrelated Spectros-
copY). Variants of the same technique were used to detect
threonine in vivo in rat (6) and human (7) brains. Recently,
a new J-difference editing method was used to quantify the
threonine concentration in the human brain by discrimi-
nating between the lactate and threonine resonance at
1.32 ppm based on selective refocusing of the J-coupled
partner at 4.11 ppm and 4.24 ppm (8). The results indi-
cated that threonine (0.56  0.06 mM) was present at
slightly higher concentration than lactate (0.47 
0.07 mM) in the human occipital cortex (8). This differ-
ence editing method required many scans (around 768) to
obtain information about both lactate and threonine and
was very sensitive to frequency variations because the
selective pulses had a bandwidth of 15 Hz. Additionally,
the signal at 1.32 ppm could be contaminated with lipids
and lead to subtraction artifacts due to subject motion.
A single-shot editing using through-bond polarization
transfer (TOtal Correlation SpectroscopY, TOCSY; 9–11)
between closest protons has been recently used in in vivo
studies to detect -aminobutyric acid (GABA) at 3 Tesla
(T) in the human brain (12) and to detect the considerably
weaker signal of -glucose under the water peak in rat and
human brains and to detect lactate under the lipid reso-
nances in the rat brain (13).
In this study, a single-shot 1D-TOCSY-LASER (13) tech-
nique is used to measure the concentration of threonine
alone in vivo in both rat and human brains using multiple-
bond editing involving spins that are four bonds away
from each other. The quantitative measurement of the
concentration of threonine in vivo in the rat brain was
performed and independently conﬁrmed with brain ex-
tracts.
MATERIALS AND METHODS
Molecules
Lactate is an A3X spin system with three methyl protons
and one methine proton (14). The 1H spectrum consists of
a doublet at 1.32 ppm corresponding to the methyl group
and a quartet at 4.11 ppm corresponding to the methine
group. The J-coupling between the groups is 6.93 Hz.
Threonine is an A3MX spin system with ﬁve nonlabile
protons from a CH3 and two CH groups (14). The 2CH
proton gives a doublet at 3.58 ppm (J23-coupling 4.92 Hz),
and the 3CH proton resonates at 4.24 ppm as an eight-line
multiplet due to its coupling with the 2CH and 4CH3 pro-
tons. The 4CH3 protons give a doublet at 1.32 ppm due to
coupling with the 3CH proton (J34-coupling 6.35 Hz).
Pulse Sequence: Principle
A 1D-TOCSY-LASER (13) sequence was optimized for de-
tection of the threonine proton bound to 2C (3.58 ppm) by
using a multiple-bond coherence transfer. Following a wa-
ter suppression module, all resonances were excited using
a nonselective adiabatic half passage (AHP) pulse (15). A
gaussian-shaped 180° pulse was applied at 1.32 ppm with
three coherence selective gradient pulses to refocus the
source spins (protons bound to the 4C of threonine and the
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3C of lactate respectively) and to obliterate all the signals
outside of the bandwidth of the gaussian-shaped pulse.
During the mixing period, polarization transfer through
homonuclear J-couplings was performed using a scheme
reminiscent of selective TOCSY (11). Mixing was opti-
mized using a phantom at 9.4 T and 4 T to maximize signal
at 3.58 ppm. The three-dimensional (3D) localization was
performed with a LASER sequence (16) immediately after
the mixing period.
Phantom
The 1D-TOCSY-LASER editing scheme was optimized for
detection of threonine signal by using an aqueous solution
of threonine (9.7 mM) and lactate (9.7 mM). The rate of
coherence transfer for the proton resonating at 3.58 ppm
was measured at 9.4 T using 11 experiments with a mixing
time ranging from 0 to 90 ms in9-ms increments and was
measured at 4 T using four experiments with a mixing time
between 0 and 60 ms in 20-ms increments (Fig. 1).
Animals
All animal experiments were performed in accordance
with the guidelines for the care and use of laboratory
animals and were approved by the Institutional Animal
Care and Use Committee of the University of Minnesota.
Six male Spraque-Dawley rats were intubated and venti-
lated with a 70%:30% N2O:O2 mixture and 1.0%–1.5%
isoﬂurane. Body temperature was maintained at 37°C by
warm water circulation. Femoral arteries were cannulated
for blood sampling. After completion of surgery, animals
were placed in a homebuilt holder, and the head position
was ﬁxed using ear rods and a bite-bar. Blood gases were
measured every 15 min, and physiological parameters
(pH  7.42  0.06, PCO2  38  6 mmHg, PO2 
100 mmHg) were maintained within normal range with
few exceptions.
Extracts
At the end of experiments, three rats were killed using a
focused microwave ﬁxation device by applying 4 kW fo-
cused onto the brain for 1.4 s (Gerling Applied Engineering
Inc., Modesto, CA). The brain was dissected out of the
skull, immediately placed into liquid nitrogen, and stored
at 80°C. Brain tissue was manually reduced to a powder
with a mortar and pestle and extracted with 5 mL ice-cold
perchloric acid (0.9 M).
Human Subjects
Normal volunteers (n  4) were studied after giving in-
formed consent according to the procedures approved by
the Institutional Review Board of the University of Min-
nesota Medical School. Subjects were placed on a cushion
and wore earplugs to minimize acoustic noise.
In Vivo Spectroscopy: Animal
In vivo animal spectra were acquired on a 9.4 T, 31-cm
horizontal bore magnet (Magnex Scientiﬁc, Oxford, UK)
interfaced with a Varian INOVA console (Varian, Palo
Alto, CA). The magnet was equipped with an 11-cm gra-
FIG. 1. Series of 1D-TOCSY-LA-
SER spectra used to optimize the
mixing time for threonine detec-
tion at 9.4 T and 4 T using an
equal molar aqueous solution of
lactate and threonine with mixing
times ranging from 0 to 86 ms at
9.4 T and from 0 to 60 ms at 4 T.
Only the region from 3.5 to
4.4 ppm is displayed. TR  3 s,
NEX  4 at 9.4 T and TR  4 s,
NEX  16 at 4 T and 2-Hz-line-
broadening were used. thr, threo-
nine; lac, lactate
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dient insert capable of reaching 300 mT/m in 500 s (Mag-
nex Scientiﬁc, Oxford, UK). A quadrature 400-MHz 1H
radio frequency (RF) surface coil was used to transmit and
receive. Localizer T2-weighted multislice rapid acquisition
with relaxation enhancement (RARE) images (17; repeti-
tion time [TR]  5 s; echo time [TE]  60 ms; echo train
length  8; matrix  256 	 128; slice thickness  1 mm;
11 slices) were acquired to select the 6.8 	 4.3 	 6.8 mm3
volume of interest in the rat brain. Linewidths of 18 Hz for
water were obtained after the adjustment of the ﬁrst- and
second-order shims using FAST(EST)MAP (18,19).
In the 1D-TOCSY-LASER sequence, the AHP pulse du-
ration length was 4 ms, and each adiabatic full passage
(AFP) pulse in LASER was an offset-independent adiabatic
pulse, HS8 (20), using a pulse duration of Tp  0.0015 s
and a frequency sweep amplitude of A  8.33 kHz (band-
width [full width half maximum, FWHM])  2A). Selec-
tive refocusing was performed with either a 2.5-ms
(FWHM  620 Hz) or 4-ms (FWHM  380 Hz) gaussian-
shaped pulse applied at 1.32 ppm. Coherence transfer was
performed with a 69-ms-long train of AFP pulses based on
hyperbolic tangent and tangent functions (tanh/tan; 15,21)
using Tp 250 s and A 80 kHz (B1 7 kHz, FWHM
24.3 kHz). The echo time was 37 ms for the LASER mod-
ule. The echo time for the entire sequence, including both
refocusing and coherence transfer, was 114 ms. A repeti-
tion time of 3 s was used. All spectra were acquired as a
single free induction decay (FID) with 4096 complex
points and spectral width of 5 kHz and were frequency
corrected using residual N-acetylaspartate (NAA) signal at
2.01 ppm before summation. At the end of experiment, in
vivo ultra-short echo-time STEAM spectra (22) were ob-
tained for ﬁve of six rats from the same voxel (TR  5 s;
TE  3 ms; TM  20 ms; spectral width  5 kHz; number
of acquired complex points  4096; NEX  64).
In Vivo Spectroscopy: Human
In vivo human spectra were obtained on a 4 T, 90-cm
horizontal bore magnet (Oxford Magnet Technology, Ox-
ford, UK) interfaced with a Varian INOVA console (Varian,
Palo Alto, CA). The magnet was equipped with a Sonata
gradient coil (Siemens, Erlangen, Germany), which was
capable of reaching 40 mT/m in 400 s. A quadrature
169 MHz 1H surface RF coil was used to transmit and
receive. Gradient echo (TR  0.15 s; TE  17 ms; matrix 
256 	 128; slice thickness  3 mm) images were acquired
to select a 3 cm 	 5 cm 	 3 cm volume of interest in the
visual cortex. Linewidths of 9.9 Hz for water were ob-
tained after the adjustment of the ﬁrst- and second-order
shims using FAST(EST)MAP (18,19).
In the 1D-TOCSY-LASER sequence, the AHP pulse du-
ration was 4 ms, and each AFP pulse in LASER was a
hyperbolic secant pulse, HS1 (16,23,24), using Tp  0.004
s and A  2.5 kHz. Selective refocusing was performed
with either a 10-ms (FWHM  150 Hz), 12-ms (FWHM 
125 Hz) or 15-ms (FWHM  100 Hz) gaussian-shaped
pulse applied at 1.32 ppm, and the coherence transfer was
performed using a 60-ms-long train of tanh/tan pulses
(Tp  1250 s; A  16 kHz; B1  0.7 kHz; FWHM 
2.6 kHz). The echo time was 68 ms for the LASER module
and 147 ms for the entire sequence including refocusing
and coherence transfer. A repetition time of 4.5 s was used.
Each FID was acquired with 2048 complex points using a
spectral width of 3 kHz. FIDs were stored separately in
memory and were frequency and phase corrected based on
the NAA signal at 2.01 ppm before summation.
High-Resolution 1H NMR Spectroscopy
1H NMR spectra of brain extracts (n  3) were measured at
physiological temperature (37°C) under both physiological
(pH  6.8 corresponding to pD  7.2) and very low (pH 
2.7) pH conditions with a simple pulse-acquired sequence
(TR  24 s; NEX  32) using a high-resolution 600 MHz
Varian INOVA spectrometer (Varian) equipped with a
5-mm probe.
Quantiﬁcation
In vivo STEAM spectra were analyzed using an LCModel
5.2-3 (25,26; Stephen Provencher, Inc., Oakville, Ontario,
Canada), which calculated the best ﬁt of the experimental
spectrum as a linear combination of model spectra. The
experimentally observed spectra of macromolecules (1)
and the spectra of the following 18 metabolites were in-
cluded in the basis set for LCModel: alanine (Ala), aspar-
tate (Asp), creatine (Cr), GABA, glucose (Glc), glutamate
(Glu), glutamine (Gln), glutathione (GSH), glycerophos-
phorylcholine (GPC), phosphorylcholine (PCho), myo-ino-
sitol (mIns), lactate (Lac), NAA, N-acetylaspartylglutamate
(NAAG), phosphocreatine (PCr), phosphorylethanolamine
(PE), scyllo-inositol (sIns), and taurine. Quantiﬁcation was
obtained using the unsuppressed water signal measured
from the same voxel (assuming 83% brain water content)
as internal references. The LCModel ﬁtting was performed
over the spectral range from 0.5 to 4.0 ppm.
RESULTS
The change in the resonance pattern and the build-up of
signal as a function of mixing time are shown in Figure 1
for an equal molar aqueous solution of threonine and
lactate at 9.4 T and 4 T. The threonine resonance of the
2CH proton resonating at 3.58 ppm was easier to detect
than the 3CH proton resonating at 4.24 ppm due to simpler
spectral pattern. The maximum signal for the 2CH proton
was obtained at mixing time of 69 ms at 9.4 T and 60 ms at
4 T.
The 2CH resonance was unequivocally and consistently
detected at 3.58 ppm in all six in vivo rat studies as judged
from the consistent spectral pattern observed at 3.58 ppm,
which was similar to the spectral pattern measured in an
accordingly line-broadened phantom spectrum (Fig. 2A).
The assignment of the resonance was conﬁrmed by the
inability to detect it when a train of adiabatic TOCSY
pulses was turned off (not shown). The polarization was
transferred from protons resonating at 1.32 ppm (lactate
and threonine) and protons within the bandwidth of either
a 2.5-ms-long or 4-ms-long refocusing pulse, such as N-
acetylaspartate, glutamate, glutamine, and macromole-
cules. The signal from lactate at 4.11 ppm was also de-
tected and resembled the signal detected in a solution
containing lactate with application of appropriate line-
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broadening, but the other threonine signal at 4.24 ppm
could not be resolved from the macromolecules back-
ground signal. Additionally, the signal from glutamate and
glutamine was observed at 3.76 ppm. As expected, the
signal intensity of glutamate and glutamine was reduced
when a 4 ms (narrower bandwidth) was used rather than a
2.5-ms gaussian-shaped pulse (Fig. 2B).
LCModel analysis of a representative in vivo STEAM
spectrum is shown in Figure 3A. A close match between
the LCModel ﬁt and the STEAM spectrum was achieved,
as evidenced by the ﬂat residual especially around the
region of interest at 1.32 ppm. The peak at 1.32 ppm,
which is the sum of lactate and threonine, was quantiﬁed
with an average Cramer-Rao Lower Bound (CRLB) of 5%
resulting in a 3.2 mM concentration. The concentration of
lactate is high due to the use of isoﬂurane as anesthesia.
High-resolution spectra of the rat brain extracts were
obtained at physiological (pH 6.8 corresponding to pD
7.2) and very low (pH  2.7) pH to demonstrate the pres-
ence of overlapping lactate and threonine signals (Fig. 3B).
The overlapping signals of threonine and lactate at
1.32 ppm at pH  6.8 were completely resolved at pH 
2.7. Threonine and lactate in this particular extract con-
tributed 20% and 80%, respectively, to the signal intensity
at 1.32 ppm.
Two different methods were used to independently
quantify the threonine concentration. In the ﬁrst method,
the threonine concentration was quantiﬁed with respect to
residual NAA signal using a 1D-TOCSY-LASER spectra
with taking into consideration the efﬁciency of the TOCSY
transfer obtained from a phantom. The concentration of
NAA was known from quantiﬁed STEAM spectra. The
threonine concentration was 0.8 0.3 mM assuming iden-
tical T1 and T2 for threonine, NAA, and creatine. In the
second method, the total (threonine 
 lactate) signal at
1.32 ppm quantiﬁed from the STEAM spectra and the ratio
of threonine to lactate obtained from extract were used to
quantify the threonine concentration. Using this method,
threonine concentration was 0.6  0.2 mM and lactate
concentration was 2.7  0.6 mM. The concentrations of
threonine obtained by two methods were within standard
deviations of each other.
Figure 4A shows the effect of the length of the gaussian-
shaped pulse on the ability to detect the threonine signal at
3.58 ppm using a 1D-TOCSY-LASER sequence at 4 T. As
was observed at 9.4 T, the narrower the bandwidth of the
gaussian-shaped pulse, the smaller the glutamate and glu-
tamine signals were at 3.76 ppm. The glutamate and glu-
tamine resonance at 3.76 ppm under the parameters used
for editing at 4 T were in the dispersive mode which was
further conﬁrmed using a glutamate phantom at 4 T and by
increasing the lengths of the LASER and mixing pulses at
9.4 T to match those at 4 T (not shown).
The 2CH resonance was unequivocally and consistently
detected at 3.58 ppm in all four in vivo human studies as
judged from the consistent spectral pattern at 3.58 ppm,
which was similar to the spectral pattern measured in an
accordingly line-broadened phantom spectrum (Fig. 4B).
Also, the lactate signal at 4.11 ppm was detected, but the
other threonine signal at 4.24 ppm could not be resolved
from the macromolecules’ background signal. The quanti-
ﬁcation of threonine proved to be difﬁcult in the individ-
ual subjects, but based on the lactate concentration in the
summed spectrum and the expected signal recovery (mea-
sured on phantom), the concentration of threonine was
estimated to be 0.33 mM.
FIG. 2. The consistent detection of threonine in vivo in the rat brains
using 1D-TOCSY-LASER. A: The spectra from six separate experi-
ments and the sum of all those spectra are presented. Each in vivo
spectrum was acquired in approximately 27 min from a 164 L voxel.
The spectra are shown with similar linewidths and with the amplitude
adjusted using the residual NAA signal at 2.01 ppm. TR  3 s, NEX 
512 for each spectrum, mixing time  69 ms, and a 4-ms gaussian-
shaped pulse were used. The inset shows part of the spectrum around
the threonine and lactate resonances obtained with a 1D-TOCSY-LASER
editing of an equal molar aqueous threonine and lactate solution. The
linewidths have been broadened to reﬂect in vivo linewidths.B: The effect
of using either a 2.5-ms or a 4-ms gaussian-shaped pulse is shown. NAA,
N-acetylaspartate; ala, alanine; glu, glutamate; gln, glutamine
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DISCUSSION
In this study, the threonine signal was unequivocally de-
tected in vivo in the rat brain and in the human brain using
a single-shot 1D-TOCSY-LASER method. In the case of
threonine, a multiple-bond polarization transfer across
four bonds was used, and the signal at 3.58 ppm was
detected. The polarization was transferred across four
bonds. The polarization from the 1.32 ppm peak was trans-
ferred initially to the 4.24 ppm peak, which was subse-
quently transferred to the 3.58 ppm peak. The detection of
the threonine signal at 4.24 ppm was not possible due to
the dispersion of the threonine signal and its overlap with
the intense signal from macromolecules at 4.23 ppm and
4.30 ppm. The 1D-TOCSY-LASER data are consistent with
the connectivity assignments for the macromolecule reso-
nances, M1 (1.24 ppm), M2 (1.43 ppm), and M3
(1.72 ppm), which resonated within the bandwidth of the
selective gaussian-shaped pulse and were connected to the
resonances at 4.23 ppm, 4.30 ppm (M10), and 3.00 ppm
(M7), respectively (27,28).
The concentration of threonine detected in vivo in the
rat brain using the 1D-TOCSY-LASER technique (0.8 
0.3 mM) was, within experimental error, the same as the
concentration of threonine obtained from extracts (0.6 
0.2 mM). The concentration of threonine obtained using
NAA signal as an internal reference could be inﬂuenced by
the editing efﬁciency of the residual NAA signal especially
when narrow-banded refocusing pulses are used to mini-
mize glutamate and glutamine signal at 3.76 ppm. The
concentration of threonine from extracts, which was ob-
tained by quantiﬁcation of the 1.32 ppm peak in an ultra-
short echo time STEAM spectrum, could be inﬂuenced by
FIG. 3. A: LCModel quantiﬁcation
of the representative STEAM
spectrum acquired from the same
voxel that 1D-TOCSY-LASER
spectrum. TR  5 s, TE  3 ms,
TM  20 ms, NEX  64, no line-
broadening. B: High-resolution
spectra of the whole rat brain ex-
tract at pH  6.8 and pH  2.7
obtained with a pulse-acquired
sequence using a 600 MHz spec-
trometer. TR  24 s, NEX  32,
line-broadening  0.5 Hz
FIG. 4. A: The effect of using a 10-, 12-, or a 15-ms gaussian-shaped refocusing pulse on the ability to detect threonine signal at 4 T. TR 
4 s, NEX  256, line-broadening  5 Hz. B: The consistent detection of threonine in vivo in the human brain using 1D-TOCSY-LASER. Each
spectrum was acquired in approximately 20 min from a 45-mL voxel placed in the occipital lobe. Spectra are shown with similar linewidths
and with the amplitude adjusted using macromolecules signal at 4.35 ppm. TR  4.5 s, NEX  256, mixing time  60 ms, and a 15-ms
gaussian-shaped pulse were used. The inset shows part of the spectrum around the threonine and lactate resonances obtained with the
1D-TOCSY-LASER editing of an equal molar aqueous threonine and lactate solution. The linewidths have been broadened to reﬂect the in
vivo linewidths.
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the slight buildup of lactate during the process of micro-
wave ﬁxation. The concentration of threonine was signif-
icantly lower than the concentration of lactate which was
in agreement with normal physiology under isoﬂurane
anesthesia (1).
The threonine signal was also detected in vivo in the
human brain using the 1D-TOCSY-LASER method and the
concentration of threonine was estimated to be 0.33 mM,
which was approximately two times lower than the concen-
tration of lactate. Of interest, the estimated lactate concentra-
tion was substantially below 1 mM, which is in excellent
agreement with the 0.5 mM lactate concentration estimated
from 13C turnover studies (29). The efﬁciency of the detection
of the threonine signal in the human brain at 4 T was not
optimal due to the inability of performing scan to scan fre-
quency correction using NAA signal and due to SAR limita-
tions, which required either using a shorter mixing time or
making the mixing pulses sub-adiabatic. The second option
was used to obtain the human data at 4 T.
Measurement of threonine in the human brain was re-
cently reported using a difference J-editing technique and
yielded estimates of threonine concentrations with a stan-
dard deviation of 0.06 mM (precision of 10%) (8). The
standard deviation of threonine measurement using 1D-
TOCSY-LASER in the present work in the rat brain was
0.2 mM (30%) and is consistent with the typical 2% Cra-
mer-Rao lower bounds obtained when measuring much
more strongly represented NAA signal at TE  2 ms,
amounting to an absolute error of 0.2 mM. Although
based on the precision J-editing may be preferable to 1D-
TOCSY-LASER editing for measurement of threonine, the
use of single-shot detection may still be advantageous in
situations in which movement cannot be avoided because
1D-TOCSY-LASER is less sensitive to frequency shifts
(pulses in (8) are very narrow). In that case, sufﬁcient
precision can be obtained by more averaging at the ex-
pense of total acquisition time.
It is worth noting that, although implementation of the
technique was similar to our previous study (13), the
present work demonstrates for the ﬁrst time the feasibility
of in vivo editing through multiple C–C bonds, which
cannot typically be achieved with J-editing in vivo due to
the low value of long range J-couplings. Editing of threo-
nine using this method demonstrates the feasibility of this
approach, which may prove useful for detection of com-
pounds that cannot be edited using conventional editing.
The detection of threonine and quantiﬁcation of threo-
nine in vivo in rat and human brain shine a new light on
the previous studies related to the lactate detection and on
the assignment of the peak at 1.32 ppm. In previously
published work that introduced the 1D-TOCSY-LASER
technique (13), the selective refocusing pulse placed at
4.11 ppm included lactate at 4.11 ppm (100% of signal
refocused) and threonine at 4.24 ppm (93% of the signal
refocused). During polarization transfer, the signal
buildup at 1.32 ppm came from both lactate and threonine.
In postmortem spectra, the majority of the signal came
from lactate. The contribution of threonine to the signal at
1.32 ppm can be reduced using a more narrowband selec-
tive refocusing pulse, for example, when 20-ms gaussian-
shape pulse is used only 23% of threonine signal is refo-
cused. In the studies investigating metabolism in the acti-
vated human visual cortex at 7 T (2,30), the peak at
1.32 ppm should be assigned to both lactate and threonine.
However, there is no evidence of change of threonine
concentration under stimulation in the difference spec-
trum (30), nor is there a known biochemical mechanism
linking functional activation with threonine biosynthesis.
In conclusion, this study established that the threonine
can be reproducibly detected in vivo in both rat and hu-
man brains by using 1D-TOCSY-LASER. Approximately
one-third of the signal at 1.32 ppm belongs to threonine
and two thirds of the signal at 1.32 ppm belongs to lactate
in the human brain. To correctly quantify lactate concen-
tration using 1.32 ppm peak, the concentration of threo-
nine has to be taken into consideration.
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